Therapeutic targeting of liver cancer with a recombinant DNA vaccine containing the hemagglutinin-neuraminidase gene of Newcastle disease virus via apoptotic-dependent pathways

A total of ~38.6 million mortalities occur due to liver cancer annually, worldwide. Although a variety of therapeutic methods are available, the efficacy of treatment at present is extremely limited due to an increased risk of malignancy and inherently poor prognosis of liver cancer. Gene therapy is...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Li-Gang, Liu, Yuan-Sheng, Zheng, Tang-Hui, Chen, Xu, Li, Ping, Xiao, Chuan-Xing, Ren, Jian-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5103948/
https://www.ncbi.nlm.nih.gov/pubmed/27900002
http://dx.doi.org/10.3892/ol.2016.5114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5103948/
https://www.ncbi.nlm.nih.gov/pubmed/27900002
http://dx.doi.org/10.3892/ol.2016.5114

Ejemplares similares